DOCSLIB.ORG

Avian Influenza Virus M2e Protein: Epitope Mapping, Competitive ELISA and Phage Displayed Scfv for DIVA in H5N1 Serosurveillance

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Avian Influenza Virus M2e Protein: Epitope Mapping, Competitive ELISA and Phage Displayed Scfv for DIVA in H5N1 Serosurveillance Avian Influenza virus M2e protein: Epitope mapping, competitive ELISA and phage displayed scFv for DIVA in H5N1 serosurveillance Noor Haliza Hasan A thesis submitted for the degree of Doctor of Philosophy School of Animal Veterinary Sciences The University of Adelaide Australia March 2017 1 Table of Contents Abstract………………………………………………………………………………………..v Thesis declaration …………………………………………………………………………...vii Acknowledgement ………………………………………………………………………… viii List of Tables ………………………………………………………………………………...xi List of Figures …………………………………………………………………………… xiii List of Abbreviations ………………………………………………………………………xvii List of Publications …………………………………………………………………………xix Introduction and Literature review ................................................ 1 Introduction ........................................................................................................... 3 Thesis outline ......................................................................................................... 5 Avian Influenza Virus (AIV): enzootic H5N1 and DIVA test in Indonesia ......... 6 AIV genes, M2 and M2e protein ........................................................................... 7 M2 protein ........................................................................................................... 11 M2e as potential universal vaccine ...................................................................... 12 M2e as DIVA marker .......................................................................................... 13 Antigenic mapping .............................................................................................. 14 Antibody and Antigenic determinants ................................................................. 15 M2e antigenic determinants ................................................................................ 17 Enzyme-linked immunosorbent assay (ELISA) for AIV surveillance and DIVA .............................................................................................................................................. 19 ELISA principles, components and types ........................................................... 19 AIV and ELISA ................................................................................................... 23 Phage display technology .................................................................................... 24 Naïve and immunized library as a source of phage library ................................. 26 Filamentous bacteriophage for phage display ..................................................... 27 Recombinant antibody display format ................................................................. 28 Phagemid as phage display vector ....................................................................... 30 Research Rationale and Aims .............................................................................. 32 References ........................................................................................................... 33 Avian influenza virus and DIVA strategies .................................. 52 Avian influenza virus (AIV) ................................................................................ 55 i2 Gene segments and proteins ................................................................................ 55 AIV transmissibility ............................................................................................ 56 AIV evolution ...................................................................................................... 56 AIV pathogenicity ............................................................................................... 57 LPAIV and HPAIV in poultry ............................................................................. 58 Virulence shift of LPAIV to HPAIV ................................................................... 58 Evolutionary pattern of H5N1 ............................................................................. 59 AIV and vaccination ............................................................................................ 61 Current understanding of DIVA strategies for AIV ............................................ 62 Sentinel birds ....................................................................................................... 63 Recombinant subunit vaccines ............................................................................ 63 Heterologous NA vaccine .................................................................................... 64 AIV nonstructural 1 (NS1) protein: Differential immune response .................... 65 Matrix 2 ectodomain (M2e) protein: Highly conserved protein.......................... 66 Haemagglutinin subunit 2 (HA2) glycoprotein (gp): Highly conserved epitope 66 DIVA strategies applicability and developments ................................................ 69 DIVA vaccine-based strategies: recombinant subunit and heterologous NA ..... 69 DIVA test-based strategies: NS1, M2e and HA2 proteins .................................. 71 Recommendations for DIVA programs ............................................................... 79 Acknowledgements ............................................................................................. 80 References ........................................................................................................... 80 Epitope mapping of avian influenza M2e protein: different species recognise various epitopes ................................................. 94 Introduction ......................................................................................................... 98 Material & Methods .......................................................................................... 100 Peptides for mouse and rabbit immunization and antigenic mapping ............... 100 Antibodies (sera) ............................................................................................... 101 Indirect M2e-ELISA and antigenic mapping .................................................... 104 Statistical and bioinformatics analyses .............................................................. 105 Ethics statement ................................................................................................. 105 Results ............................................................................................................... 106 Chicken, mouse and rabbit antibodies selection using indirect-M2e ELISA .... 106 Chicken sera recognized at least 2 different epitopes spanning M2e residue 5-18 and 10-17 ........................................................................................................... 106 Chicken sera reactivity pattern is highly influenced by its immunogen as well as individual chicken immune response ................................................................ 111 3 ii Mouse monoclonal antibodies recognized epitopes M2e2-18 and M2e11-18 while rabbit polyclonal antibodies recognized epitope M2e6-13 .................................. 111 Discussion .......................................................................................................... 114 Acknowledgment ............................................................................................... 120 References ......................................................................................................... 120 Characterization of monoclonal antibodies to the avian influenza virus H5N1 M2e protein and their potential use for diagnostic tool competitive ELISA development ......................................... 127 Introductions ...................................................................................................... 130 Material and Methods ........................................................................................ 133 M2e peptide as antigen for indirect and competitive ELISA ............................ 133 Monoclonal antibody (mAb) ............................................................................. 133 Sera .................................................................................................................... 134 Indirect M2e-ELISA .......................................................................................... 136 Development and Standardization of competitive ELISA ................................ 137 Data analysis and statistics ................................................................................ 138 Results ............................................................................................................... 138 Chicken polyclonal and mouse monoclonal antibodies anti-M2e titers ............ 138 Selection of mAb 3H4 as the competitor in M2e-based competitive ELISA ... 138 cELISA using mAb 3H4 distinguished infected from vaccinated chicken sera 139 Sensitivity and specificity of M2e-based cELISA ............................................ 143 Discussion .......................................................................................................... 144 Acknowledgement ............................................................................................. 148 References ......................................................................................................... 148 Isolation of reactive single-chain variable fragment antibodies against AIV-M2e protein (scFv anti-M2e) using phage display technology from H5N1-immunized chicken IgY ....................... 153 Introduction
Load more

Recommended publications
  • Guide for Common Viral Diseases of Animals in Louisiana
    Sampling and Testing Guide for Common Viral Diseases of Animals in Louisiana Please click on the species of interest: Cattle Deer and Small Ruminants The Louisiana Animal Swine Disease Diagnostic Horses Laboratory Dogs A service unit of the LSU School of Veterinary Medicine Adapted from Murphy, F.A., et al, Veterinary Virology, 3rd ed. Cats Academic Press, 1999. Compiled by Rob Poston Multi-species: Rabiesvirus DCN LADDL Guide for Common Viral Diseases v. B2 1 Cattle Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 2 Deer and Small Ruminants Please click on the principle system involvement Generalized viral disease Respiratory viral disease Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 3 Swine Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 4 Horses Please click on the principle system involvement Generalized viral diseases Neurological viral diseases Respiratory viral diseases Enteric viral diseases Abortifacient/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 5 Dogs Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Back to the Beginning DCN LADDL Guide for Common Viral Diseases v.
    [Show full text]
  • Functional Studies of the Coronavirus Nonstructural Proteins Yanglin QIU and Kai XU*
    REVIEW ARTICLE Functional studies of the coronavirus nonstructural proteins Yanglin QIU and Kai XU* Jiangsu Key Laboratory for Microbes and Functional Genomics, College of Life Sciences, Nanjing Normal University, Nanjing 210023, P. R. China. *Correspondence: [email protected] https://doi.org/10.37175/stemedicine.v1i2.39 ABSTRACT Coronaviruses, including SARS-CoV, SARS-CoV-2, and MERS-CoV, have caused contagious and fatal respiratory diseases in humans worldwide. Notably, the coronavirus disease 19 (COVID-19) caused by SARS-CoV-2 spread rapidly in early 2020 and became a global pandemic. The nonstructural proteins of coronaviruses are critical components of the viral replication machinery. They function in viral RNA transcription and replication, as well as counteracting the host innate immunity. Studies of these proteins not only revealed their essential role during viral infection but also help the design of novel drugs targeting the viral replication and immune evasion machinery. In this review, we summarize the functional studies of each nonstructural proteins and compare the similarities and differences between nonstructural proteins from different coronaviruses. Keywords: Coronavirus · SARS-CoV-2 · COVID-19 · Nonstructural proteins · Drug discovery Introduction genes (18). The first two major ORFs (ORF1a, ORF1ab) The coronavirus (CoV) outbreaks among human are the replicase genes, and the other four encode viral populations have caused three major epidemics structural proteins that comprise the essential protein worldwide, since the beginning of the 21st century. These components of the coronavirus virions, including the spike are the epidemics of the severe acute respiratory syndrome surface glycoprotein (S), envelope protein (E), matrix (SARS) in 2003 (1, 2), the Middle East respiratory protein (M), and nucleocapsid protein (N) (14, 19, 20).
    [Show full text]
  • Print Special Issue Flyer
    IMPACT FACTOR 5.923 an Open Access Journal by MDPI Proteins in Human Diseases: Molecular Insights into Drug Targets and Novel Therapeutic Modalities Guest Editors: Message from the Guest Editors Dr. Joo Hyoung Lee Proteins are fundamental biomolecules that modulate 1. R&D Center - PharmAbcine Inc., diverse cellular and molecular events in living organisms. Daejeon, Korea 2. Department of Pathology, The Scientific studies have established that aberrant levels of University of Alabama at proteins due to the dysregulation of gene transcription Birmingham, Birmingham, AL, USA cause various pathophysiological dysfunctions in humans. [email protected] In this regard, tremendous scientific endeavors and translational research efforts have been made to identify Dr. Tae-Don Kim the functions of the involved proteins and to develop Immunotherapy Research Center, Korea Research Institute of treatment modalities for disease management. Bioscience and Biotechnology, Yuseong-gu, Daejeon 34141, Korea This Special Issue will collect reviews, perspectives and opinions, and research articles covering various topics, [email protected] with the aim to present less known molecular aspects of proteins that can be targeted to develop novel therapy modalities for various diseases. In this regard, as a former Deadline for manuscript scientist in an academic institution and a current primary submissions: investigator in the industry, the editor urges his Colleagues closed (28 February 2021) to communicate outstanding research findings for publication in this Special Issue as a valuable contribution to protein science. mdpi.com/si/58496 SpeciaIslsue IMPACT FACTOR 5.923 an Open Access Journal by MDPI Editor-in-Chief Message from the Editor-in-Chief Prof.
    [Show full text]
  • A Scoping Review of Viral Diseases in African Ungulates
    veterinary sciences Review A Scoping Review of Viral Diseases in African Ungulates Hendrik Swanepoel 1,2, Jan Crafford 1 and Melvyn Quan 1,* 1 Vectors and Vector-Borne Diseases Research Programme, Department of Veterinary Tropical Disease, Faculty of Veterinary Science, University of Pretoria, Pretoria 0110, South Africa; [email protected] (H.S.); [email protected] (J.C.) 2 Department of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium * Correspondence: [email protected]; Tel.: +27-12-529-8142 Abstract: (1) Background: Viral diseases are important as they can cause significant clinical disease in both wild and domestic animals, as well as in humans. They also make up a large proportion of emerging infectious diseases. (2) Methods: A scoping review of peer-reviewed publications was performed and based on the guidelines set out in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews. (3) Results: The final set of publications consisted of 145 publications. Thirty-two viruses were identified in the publications and 50 African ungulates were reported/diagnosed with viral infections. Eighteen countries had viruses diagnosed in wild ungulates reported in the literature. (4) Conclusions: A comprehensive review identified several areas where little information was available and recommendations were made. It is recommended that governments and research institutions offer more funding to investigate and report viral diseases of greater clinical and zoonotic significance. A further recommendation is for appropriate One Health approaches to be adopted for investigating, controlling, managing and preventing diseases. Diseases which may threaten the conservation of certain wildlife species also require focused attention.
    [Show full text]
  • SCIENCE CITATION INDEX EXPANDED - JOURNAL LIST Total Journals: 8631
    SCIENCE CITATION INDEX EXPANDED - JOURNAL LIST Total journals: 8631 1. 4OR-A QUARTERLY JOURNAL OF OPERATIONS RESEARCH 2. AAPG BULLETIN 3. AAPS JOURNAL 4. AAPS PHARMSCITECH 5. AATCC REVIEW 6. ABDOMINAL IMAGING 7. ABHANDLUNGEN AUS DEM MATHEMATISCHEN SEMINAR DER UNIVERSITAT HAMBURG 8. ABSTRACT AND APPLIED ANALYSIS 9. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 10. ACADEMIC EMERGENCY MEDICINE 11. ACADEMIC MEDICINE 12. ACADEMIC PEDIATRICS 13. ACADEMIC RADIOLOGY 14. ACCOUNTABILITY IN RESEARCH-POLICIES AND QUALITY ASSURANCE 15. ACCOUNTS OF CHEMICAL RESEARCH 16. ACCREDITATION AND QUALITY ASSURANCE 17. ACI MATERIALS JOURNAL 18. ACI STRUCTURAL JOURNAL 19. ACM COMPUTING SURVEYS 20. ACM JOURNAL ON EMERGING TECHNOLOGIES IN COMPUTING SYSTEMS 21. ACM SIGCOMM COMPUTER COMMUNICATION REVIEW 22. ACM SIGPLAN NOTICES 23. ACM TRANSACTIONS ON ALGORITHMS 24. ACM TRANSACTIONS ON APPLIED PERCEPTION 25. ACM TRANSACTIONS ON ARCHITECTURE AND CODE OPTIMIZATION 26. ACM TRANSACTIONS ON AUTONOMOUS AND ADAPTIVE SYSTEMS 27. ACM TRANSACTIONS ON COMPUTATIONAL LOGIC 28. ACM TRANSACTIONS ON COMPUTER SYSTEMS 29. ACM TRANSACTIONS ON COMPUTER-HUMAN INTERACTION 30. ACM TRANSACTIONS ON DATABASE SYSTEMS 31. ACM TRANSACTIONS ON DESIGN AUTOMATION OF ELECTRONIC SYSTEMS 32. ACM TRANSACTIONS ON EMBEDDED COMPUTING SYSTEMS 33. ACM TRANSACTIONS ON GRAPHICS 34. ACM TRANSACTIONS ON INFORMATION AND SYSTEM SECURITY 35. ACM TRANSACTIONS ON INFORMATION SYSTEMS 36. ACM TRANSACTIONS ON INTELLIGENT SYSTEMS AND TECHNOLOGY 37. ACM TRANSACTIONS ON INTERNET TECHNOLOGY 38. ACM TRANSACTIONS ON KNOWLEDGE DISCOVERY FROM DATA 39. ACM TRANSACTIONS ON MATHEMATICAL SOFTWARE 40. ACM TRANSACTIONS ON MODELING AND COMPUTER SIMULATION 41. ACM TRANSACTIONS ON MULTIMEDIA COMPUTING COMMUNICATIONS AND APPLICATIONS 42. ACM TRANSACTIONS ON PROGRAMMING LANGUAGES AND SYSTEMS 43. ACM TRANSACTIONS ON RECONFIGURABLE TECHNOLOGY AND SYSTEMS 44.
    [Show full text]
  • Risk Groups: Viruses (C) 1988, American Biological Safety Association
    Rev.: 1.0 Risk Groups: Viruses (c) 1988, American Biological Safety Association BL RG RG RG RG RG LCDC-96 Belgium-97 ID Name Viral group Comments BMBL-93 CDC NIH rDNA-97 EU-96 Australia-95 HP AP (Canada) Annex VIII Flaviviridae/ Flavivirus (Grp 2 Absettarov, TBE 4 4 4 implied 3 3 4 + B Arbovirus) Acute haemorrhagic taxonomy 2, Enterovirus 3 conjunctivitis virus Picornaviridae 2 + different 70 (AHC) Adenovirus 4 Adenoviridae 2 2 (incl animal) 2 2 + (human,all types) 5 Aino X-Arboviruses 6 Akabane X-Arboviruses 7 Alastrim Poxviridae Restricted 4 4, Foot-and- 8 Aphthovirus Picornaviridae 2 mouth disease + viruses 9 Araguari X-Arboviruses (feces of children 10 Astroviridae Astroviridae 2 2 + + and lambs) Avian leukosis virus 11 Viral vector/Animal retrovirus 1 3 (wild strain) + (ALV) 3, (Rous 12 Avian sarcoma virus Viral vector/Animal retrovirus 1 sarcoma virus, + RSV wild strain) 13 Baculovirus Viral vector/Animal virus 1 + Togaviridae/ Alphavirus (Grp 14 Barmah Forest 2 A Arbovirus) 15 Batama X-Arboviruses 16 Batken X-Arboviruses Togaviridae/ Alphavirus (Grp 17 Bebaru virus 2 2 2 2 + A Arbovirus) 18 Bhanja X-Arboviruses 19 Bimbo X-Arboviruses Blood-borne hepatitis 20 viruses not yet Unclassified viruses 2 implied 2 implied 3 (**)D 3 + identified 21 Bluetongue X-Arboviruses 22 Bobaya X-Arboviruses 23 Bobia X-Arboviruses Bovine 24 immunodeficiency Viral vector/Animal retrovirus 3 (wild strain) + virus (BIV) 3, Bovine Bovine leukemia 25 Viral vector/Animal retrovirus 1 lymphosarcoma + virus (BLV) virus wild strain Bovine papilloma Papovavirus/
    [Show full text]
  • Available for Replication DAVID A
    JOURNAL OF VIROLOGY, Nov. 1988, p. 4201-4206 Vol. 62, No. 11 0022-538X/88/114201-06$02.00/0 Copyright ©D 1988, American Society for Microbiology Restricted Replication of Hepatitis A Virus in Cell Culture: Encapsidation of Viral RNA Depletes the Pool of RNA Available for Replication DAVID A. ANDERSON,* BRUCE C. ROSS, AND STEPHEN A. LOCARNINI Macfarlane Burnet Centre for Medical Research, Fairfield Hospital, Fairfield, Victoria 3078, Australia Received 23 May 1988/Accepted 31 July 1988 The replication of hepatitis A virus (HAV) in BS-C-1 cells was examined under single-cycle growth conditions by using strand-specific probes for detection of viral RNA species. No measurable lag phase was demonstrated between accumulation of positive-strand HAV RNA and production of infectious virions, indicating that replication of virion RNA is rate limiting for the production of infectious virus. Intracellular viral RNA was further analyzed by using 2 M LiCl to fractionate the insoluble nonvirion 35S RNA and replicative intermediates (RI) from the soluble virions and double-stranded replicative forms, in conjunction with sucrose density gradient ultracentrifugation to separate the different forms of viral RNA. Throughout the productive phase of HAV infection, 95 to 97% of positive-strand HAV RNA was soluble in 2 M LiCl and was shown to be contained in mature virions. Of the LiCl-insoluble HAV RNA, more than 99% was positive-stranded 35S RNA, whereas 0.4% was negative stranded and had the sedimentation and partial RNase resistance characteristics of RI. The pattern of RNA accumulation in HAV.infected cells is thus very different from that seen in poliovirus-infected cells, where large pools of RI and mRNA are produced before RNA is sequestered into mature virions.
    [Show full text]
  • Ancient Recombination Events and the Origins of Hepatitis E Virus Andrew G
    Kelly et al. BMC Evolutionary Biology (2016) 16:210 DOI 10.1186/s12862-016-0785-y RESEARCH ARTICLE Open Access Ancient recombination events and the origins of hepatitis E virus Andrew G. Kelly, Natalie E. Netzler and Peter A. White* Abstract Background: Hepatitis E virus (HEV) is an enteric, single-stranded, positive sense RNA virus and a significant etiological agent of hepatitis, causing sporadic infections and outbreaks globally. Tracing the evolutionary ancestry of HEV has proved difficult since its identification in 1992, it has been reclassified several times, and confusion remains surrounding its origins and ancestry. Results: To reveal close protein relatives of the Hepeviridae family, similarity searching of the GenBank database was carried out using a complete Orthohepevirus A, HEV genotype I (GI) ORF1 protein sequence and individual proteins. The closest non-Hepeviridae homologues to the HEV ORF1 encoded polyprotein were found to be those from the lepidopteran-infecting Alphatetraviridae family members. A consistent relationship to this was found using a phylogenetic approach; the Hepeviridae RdRp clustered with those of the Alphatetraviridae and Benyviridae families. This puts the Hepeviridae ORF1 region within the “Alpha-like” super-group of viruses. In marked contrast, the HEV GI capsid was found to be most closely related to the chicken astrovirus capsid, with phylogenetic trees clustering the Hepeviridae capsid together with those from the Astroviridae family, and surprisingly within the “Picorna-like” supergroup. These results indicate an ancient recombination event has occurred at the junction of the non-structural and structure encoding regions, which led to the emergence of the entire Hepeviridae family.
    [Show full text]
  • Unconventional Viral Gene Expression Mechanisms As Therapeutic Targets
    Review Unconventional viral gene expression mechanisms as therapeutic targets https://doi.org/10.1038/s41586-021-03511-5 Jessica Sook Yuin Ho1,3, Zeyu Zhu1,3 & Ivan Marazzi1,2 ✉ Received: 8 June 2020 Accepted: 22 March 2021 Unlike the human genome that comprises mostly noncoding and regulatory sequences, Published online: 19 May 2021 viruses have evolved under the constraints of maintaining a small genome size while expanding the efciency of their coding and regulatory sequences. As a result, viruses Check for updates use strategies of transcription and translation in which one or more of the steps in the conventional gene–protein production line are altered. These alternative strategies of viral gene expression (also known as gene recoding) can be uniquely brought about by dedicated viral enzymes or by co-opting host factors (known as host dependencies). Targeting these unique enzymatic activities and host factors exposes vulnerabilities of a virus and provides a paradigm for the design of novel antiviral therapies. In this Review, we describe the types and mechanisms of unconventional gene and protein expression in viruses, and provide a perspective on how future basic mechanistic work could inform translational eforts that are aimed at viral eradication. Expression of a gene in the human genome is a multistep and heavily (for example, alternative splicing) or use unique strategies. Here we regulated process that resembles a production line. Protein-coding describe the diverse ways by which viral genomes give rise to genes and genes are transcribed almost exclusively by RNA polymerase II (RNAPII). proteins that deviate from the canonical framework of human genes, During transcription, quality-control checkpoints are implemented to restricting our analyses to eukaryotes and their viruses.
    [Show full text]
  • JOURNAL of PROTEOMICS an Official Journal of the European Proteomics Association (Eupa)
    JOURNAL OF PROTEOMICS An official journal of the European Proteomics Association (EuPA) AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.5 ISSN: 1874-3919 DESCRIPTION . Journal of Proteomics is aimed at protein scientists and analytical chemists in the field of proteomics, biomarker discovery, protein analytics, plant proteomics, microbial and animal proteomics, human studies, tissue imaging by mass spectrometry, non-conventional and non-model organism proteomics, and protein bioinformatics. The journal welcomes papers in new and upcoming areas such as metabolomics, genomics, systems biology, toxicogenomics, pharmacoproteomics. Journal of Proteomics unifies both fundamental scientists and clinicians, and includes translational research. Suggestions for reviews, webinars and thematic issues are welcome. All manuscripts are strictly peer reviewed and conform the highest ethical standards. Journal of Proteomics is an official journal of the European Proteomics Association (EuPA) and also publishes official EuPA reports and participates in the International Proteomics Tutorial Programme with HUPO and other partners. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center Should you have an idea for a thematic issue, please complete the thematic issue proposal form and send it to the Editorial Office (Ms. Carly Middendorp, [email protected]).
    [Show full text]
  • Structure Unveils Relationships Between RNA Virus Polymerases
    viruses Article Structure Unveils Relationships between RNA Virus Polymerases Heli A. M. Mönttinen † , Janne J. Ravantti * and Minna M. Poranen * Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Viikki Biocenter 1, P.O. Box 56 (Viikinkaari 9), 00014 Helsinki, Finland; heli.monttinen@helsinki.fi * Correspondence: janne.ravantti@helsinki.fi (J.J.R.); minna.poranen@helsinki.fi (M.M.P.); Tel.: +358-2941-59110 (M.M.P.) † Present address: Institute of Biotechnology, Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Viikki Biocenter 2, P.O. Box 56 (Viikinkaari 5), 00014 Helsinki, Finland. Abstract: RNA viruses are the fastest evolving known biological entities. Consequently, the sequence similarity between homologous viral proteins disappears quickly, limiting the usability of traditional sequence-based phylogenetic methods in the reconstruction of relationships and evolutionary history among RNA viruses. Protein structures, however, typically evolve more slowly than sequences, and structural similarity can still be evident, when no sequence similarity can be detected. Here, we used an automated structural comparison method, homologous structure finder, for comprehensive comparisons of viral RNA-dependent RNA polymerases (RdRps). We identified a common structural core of 231 residues for all the structurally characterized viral RdRps, covering segmented and non-segmented negative-sense, positive-sense, and double-stranded RNA viruses infecting both prokaryotic and eukaryotic hosts. The grouping and branching of the viral RdRps in the structure- based phylogenetic tree follow their functional differentiation. The RdRps using protein primer, RNA primer, or self-priming mechanisms have evolved independently of each other, and the RdRps cluster into two large branches based on the used transcription mechanism.
    [Show full text]
  • A Structure-Based Approach to Predict Stability Strengths and Weaknesses of Proteins
    bioRxiv preprint doi: https://doi.org/10.1101/2020.10.13.338046; this version posted October 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. SWOTein: A structure-based approach to predict stability Strengths and Weaknesses of prOTEINs Q. Hou1;2;3;y, F. Pucci 3;4;y, F. Ancien 3;4, J.M. Kwasigroch 3, R. Bourgeas 3;?, M. Rooman 3;4;∗ 1Department of Biostatistics, School of Public Health, Shandong University, Shandong 250002, P. R. China 2National Institute of Health Data Science of China, Shandong University, Shandong 250002, P. R. China 3Computational Biology and Bioinformatics, Universit´eLibre de Bruxelles, Brussels 1050, Belgium 4Interuniversity Institute of Bioinformatics in Brussels, Boulevard du Triomphe, 1050 Brussels, Belgium; ∗ To whom correspondence should be addressed: [email protected]. y Contributed equally to this work ? Present address: High-Throughput Crystallisation Lab, European Molecular Biology Laboratory, 38042 Grenoble, France. October 13, 2020 Abstract Motivation: Although structured proteins adopt their lowest free energy conformation in physiological conditions, the individual residues are generally not in their lowest free energy conformation. Residues that are stability weaknesses are often involved in func- tional regions, whereas stability strengths ensure local structural stability. The detection of strengths and weaknesses provides key information to guide protein engineering exper- iments aiming to modulate folding and various functional processes. Results: We developed the SWOTein predictor which identifies strong and weak residues in proteins on the basis of three types of statistical energy functions describing local in- teractions along the chain, hydrophobic forces and tertiary interactions.
    [Show full text]